ACE2 and COVID-19: In addition, our finding of increased presence of various immune-cell lineages, including T cells and NK cells, in tumors with high ACE2 expression highlights the possibility that such tumors are not only susceptible to SARS-CoV-2 infection but could also promote the severe inflammatory response observed in many patients with COVID-19.